Get the Stockscreener App
4.95
0.20%
0.010
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
A Look at Maravai LifeSciences Holdings Inc (MRVI) Shares in the Recent Past Indicates Growth - SETE News
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World
Stock Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Brokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) PT at $10.28 - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Rating of “Hold” by Analysts - ETF Daily News
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World
Understanding the 8.92% Volatility Levels of Maravai LifeSciences Holdings Inc’s (MRVI) Stock in the Past 30 Days - The News Heater
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Marketscreener.com
Maravai LifeSciences Holdings Inc (MRVI) receives a Neutral rating from Guggenheim - Knox Daily
Maravai LifeSciences Holdings Inc’s results are impressive - US Post News
Ratio Analysis: Unpacking Maravai LifeSciences Holdings Inc (MRVI)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Insider Selling: Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) General Counsel Sells 25,000 Shares of Stock - MarketBeat
Sivik Global Healthcare LLC Cuts Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
Strategic Distribution Deal: TriLink Brings Game-Changing mRNA Technology to EMEA Market - StockTitan
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 7.1%Should You Sell? - MarketBeat
Press Release Service: Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies - CRISPR Medicine News
Maravai LifeSciences expands mRNA manufacturing with new acquisition By Investing.com - Investing.com Australia
Maravai Lifesciences Acquires Molecular Assemblies' Intellectual Property, Related Assets - Marketscreener.com
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies - Business Wire
12 West Capital Management LP Reduces Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com
Game-Changing DNA Synthesis Tech Could Revolutionize CRISPR Therapy Production - StockTitan
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Traders Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 9.5%Here's Why - MarketBeat
Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpTime to Buy? - MarketBeat
Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 43%? - Simply Wall St
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Bought by Barclays PLC - Defense World
How the (MRVI) price action is used to our Advantage - Stock Traders Daily
Maravai LifeSciences Holdings (STU:MAR) Other Stockholders Equity : €0.0 Mil (As of Sep. 2024) - GuruFocus.com
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Analysts - Defense World
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 15.7%Here's What Happened - MarketBeat
Stock Traders Buy High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai Lifesciences Holdings, Inc. Eliminates Andrew Burch as President, Nucleic Acid Production - Marketscreener.com
Maravai LifeSciences Holdings Projects 2024 Revenue Near Midpoint of Guidance - MarketWatch
Maravai LifeSciences Restructures Leadership Amid Revenue Update - TipRanks
Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall - Investing.com Canada
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue - The Manila Times
Maravai LifeSciences (MRVI) Announces In-Line Preliminary 2024 Revenue - StreetInsider.com
Maravai LifeSciences Expects 2024 Revenue to Hit Mid-Range of $255-265M Guidance - StockTitan
JPMorgan Chase & Co. Raises Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
JPMorgan Chase & Co. Has $33.66 Million Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Jane Street Group LLC Sells 201,787 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Jane Street Group LLC - MarketBeat
Principal Financial Group Inc. Reduces Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):